IL6 and COVID-19: Behind the factors involved in potentiating severe COVID-19 disease in patients with obesity, a key role is played by inflammation; visceral adiposity has been shown to enhance inflammatory cytokines, such as interleukin-6 and C-reactive protein [27], which have been correlated with increased COVID-19 severe manifestations [28].